Biogen Reports Its Alzheimer’s Drug Sharply Slowed Cognitive Decline

Friday, March 20, 2015 - 22:10 in Psychology & Sociology

The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.

Read the whole article on NY Times Health

More from NY Times Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net